Josiah Staggers, | |
410 Seminole Dr Ne, Marietta, GA 30060-1241 | |
(317) 289-2593 | |
Not Available |
Full Name | Josiah Staggers |
---|---|
Gender | Male |
Speciality | Registered Nurse - General Practice |
Location | 410 Seminole Dr Ne, Marietta, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043881766 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WG0000X | Registered Nurse - General Practice | RN266361 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Josiah Staggers, 410 Seminole Dr Ne, Marietta, GA 30060-1241 Ph: (317) 289-2593 | Josiah Staggers, 410 Seminole Dr Ne, Marietta, GA 30060-1241 Ph: (317) 289-2593 |
News Archive
One of the Cystic Fibrosis Foundation's most active volunteers will carry the Olympic Torch today in Calgary as it makes its way to Vancouver for the Opening Ceremony of the 2010 Olympic Winter Games.
A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
Remission of positive and negative symptoms is the most important predictor of functional outcomes among patients with first-episode psychosis, with cognition having only a small impact, say researchers.
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
› Verified 6 days ago
Kendra Shearer, REGISTRED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1241 Channel Park Sw, Marietta, GA 30064 Phone: 404-423-2370 Fax: 770-573-7308 | |
Sarika Mishra, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 400 Tower Rd Ne Ste 200, Marietta, GA 30060 Phone: 770-422-1372 Fax: 770-999-2488 | |
Mrs. Rhonda Kim Lee, NP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-7173 | |
Nancy Marie Certain, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1640 Powers Ferry Rd, Bldg 7, Suite 300, Marietta, GA 30067 Phone: 770-988-9200 Fax: 770-988-9296 | |
Chasity Goodin-anderson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2901 Horseshoe Bend Rd Sw, Marietta, GA 30064 Phone: 770-685-4023 | |
Ms. Evelyn Kay Hale, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-9560 | |
Mrs. Barbara Adelfa Rico-eccles, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2611 Naylor Hall, Marietta, GA 30066 Phone: 678-994-1453 |